Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

McMaster University

$273,358.00

Development of a pumpless lung assist device which acts like an artificial placenta for neonates with respiratory failure.

EF 2012-13

Résumé
Respiratory failure is the major cause of morbidity among neonates with birth weights less than 1,500 g. Mechanical ventilation has dramatically improved neonatal outcome during the last decade. However, this approach is not effective enough in neonates with severe respiratory failure to prevent fatality or side-effects that lead to long-term impairment. Constructing a lung assist device (LAD) which imitates the placental gas exchange would be a milestone in innovation for neonatal medicine. Such a device would allow for additional gas exchange under end-stage lung failure when mechanical ventilation becomes inadequate. To create such a LAD we will combine and develop the following features: oxygenator with low priming volume, the extracorporeal circulation only driven by the heart (pumpless), flow control and monitor, large bore vascular access via umbilical vein and artery, hemocompatible inner surfaces (no activation of blood clotting) and effectiveness for a body weight range of 0.5-5 kg. During the last 18 months we have formed an interdisciplinary research group of physicians, engineers and students who have assisted in developing a LAD prototype as a stack of microfluidic oxygenators. Using a newborn hypoxic piglet model (n=6) we demonstrated the proof of principle. To develop inner surfaces of the LAD which do not activate blood clotting, we studied coating properties of the material using radiolabelling. To achieve a large bore access we developed the design of an expandable catheter in collaboration with a medical technology company. This artificial placenta concept has been protected by filing a provisional US Patent, No. 61526288. The proposed LAD acting as an artificial placenta will be easy to install, cost effective and can be safely operated by standard neonatal intensive care personnel. The proposed LAD could become the next leading tool to aid infants with end-stage lung failure.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
269813
Name
Fusch Christoph
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Development of a pumpless lung assist device which acts like an artificial placenta for neonates with respiratory failure.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$273,358
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Artificial Placenta
Abstract
Respiratory failure is the major cause of morbidity among neonates with birth weights less than 1,500 g. Mechanical ventilation has dramatically improved neonatal outcome during the last decade. However, this approach is not effective enough in neonates with severe respiratory failure to prevent fatality or side-effects that lead to long-term impairment. Constructing a lung assist device (LAD) which imitates the placental gas exchange would be a milestone in innovation for neonatal medicine. Such a device would allow for additional gas exchange under end-stage lung failure when mechanical ventilation becomes inadequate. To create such a LAD we will combine and develop the following features: oxygenator with low priming volume, the extracorporeal circulation only driven by the heart (pumpless), flow control and monitor, large bore vascular access via umbilical vein and artery, hemocompatible inner surfaces (no activation of blood clotting) and effectiveness for a body weight range of 0.5-5 kg. During the last 18 months we have formed an interdisciplinary research group of physicians, engineers and students who have assisted in developing a LAD prototype as a stack of microfluidic oxygenators. Using a newborn hypoxic piglet model (n=6) we demonstrated the proof of principle. To develop inner surfaces of the LAD which do not activate blood clotting, we studied coating properties of the material using radiolabelling. To achieve a large bore access we developed the design of an expandable catheter in collaboration with a medical technology company. This artificial placenta concept has been protected by filing a provisional US Patent, No. 61526288. The proposed LAD acting as an artificial placenta will be easy to install, cost effective and can be safely operated by standard neonatal intensive care personnel. The proposed LAD could become the next leading tool to aid infants with end-stage lung failure.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Fusch, Christoph; Selvaganapathy, Ponnambalam R
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $273,358~ $0~